Literature DB >> 23583036

Structure and T cell inhibition properties of B7 family member, B7-H3.

Vladimir Vigdorovich1, Udupi A Ramagopal, Eszter Lázár-Molnár, Eliezer Sylvestre, Jun Sik Lee, Kimberly A Hofmeyer, Xingxing Zang, Stanley G Nathenson, Steven C Almo.   

Abstract

T cell activity is controlled by a combination of antigen-dependent signaling through the T cell receptor and a set of auxiliary signals delivered through antigen-independent interactions, including the recognition of the B7 family of ligands. B7-H3 is a recently identified B7 family member that is strongly overexpressed in a range of cancers and correlates with poor prognosis. We report the crystal structure of murine B7-H3 at a 3 Å resolution, which provides a model for the organization of the IgV and IgC domains within the ectodomain. We demonstrate that B7-H3 inhibits T cell proliferation and show that the FG loop of the IgV domain plays a critical role in this function. B7-H3 crystallized as an unusual dimer arising from the exchange of the G strands in the IgV domains of partner molecules. This arrangement, in combination with previous reports, highlights the dynamic nature and plasticity of the immunoglobulin fold.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583036      PMCID: PMC3998375          DOI: 10.1016/j.str.2013.03.003

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  42 in total

1.  In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers.

Authors:  Junbao Yang; Andrés Jaramillo; Ruili Shi; William W Kwok; T Mohanakumar
Journal:  Hum Immunol       Date:  2004-07       Impact factor: 2.850

2.  Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure.

Authors:  Silvia Spinelli; Aline Desmyter; Leon Frenken; Theo Verrips; Mariella Tegoni; Christian Cambillau
Journal:  FEBS Lett       Date:  2004-04-23       Impact factor: 4.124

Review 3.  T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.

Authors:  Yael S Barach; Jun Sik Lee; Xingxing Zang
Journal:  Trends Mol Med       Date:  2011-01       Impact factor: 11.951

4.  Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.

Authors:  Hiroko Kobori; Masaaki Hashiguchi; Jinhua Piao; Moriyuki Kato; Patcharee Ritprajak; Miyuki Azuma
Journal:  Immunology       Date:  2010-02-05       Impact factor: 7.397

5.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

6.  A new bioinformatics analysis tools framework at EMBL-EBI.

Authors:  Mickael Goujon; Hamish McWilliam; Weizhong Li; Franck Valentin; Silvano Squizzato; Juri Paern; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2010-05-03       Impact factor: 16.971

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47.

Authors:  Deborah Hatherley; Stephen C Graham; Jessie Turner; Karl Harlos; David I Stuart; A Neil Barclay
Journal:  Mol Cell       Date:  2008-07-25       Impact factor: 17.970

Review 9.  Domain metastability: a molecular basis for immunoglobulin deposition?

Authors:  Andreas F-P Sonnen; Chao Yu; Edward J Evans; David I Stuart; Simon J Davis; Robert J C Gilbert
Journal:  J Mol Biol       Date:  2010-04-13       Impact factor: 5.469

10.  BALBES: a molecular-replacement pipeline.

Authors:  Fei Long; Alexei A Vagin; Paul Young; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-12-05
View more
  37 in total

1.  Considering B7-CD28 as a family through sequence and structure.

Authors:  Sean M West; Xiaodi A Deng
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-17

2.  Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3.

Authors:  Mahiuddin Ahmed; Ming Cheng; Qi Zhao; Yehuda Goldgur; Sarah M Cheal; Hong-fen Guo; Steven M Larson; Nai-kong V Cheung
Journal:  J Biol Chem       Date:  2015-10-20       Impact factor: 5.157

Review 3.  Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies.

Authors:  Jeong A Park; Nai-Kong V Cheung
Journal:  Cancer Treat Rev       Date:  2017-06-01       Impact factor: 12.111

4.  Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging.

Authors:  Sunitha V Bachawal; Kristin C Jensen; Katheryne E Wilson; Lu Tian; Amelie M Lutz; Jürgen K Willmann
Journal:  Cancer Res       Date:  2015-04-21       Impact factor: 12.701

Review 5.  B7-H3 role in the immune landscape of cancer.

Authors:  Jose R Castellanos; Ian J Purvis; Collin M Labak; Maheedhara R Guda; Andrew J Tsung; Kiran K Velpula; Swapna Asuthkar
Journal:  Am J Clin Exp Immunol       Date:  2017-06-15

6.  Structure and cancer immunotherapy of the B7 family member B7x.

Authors:  Hyungjun Jeon; Vladimir Vigdorovich; Sarah C Garrett-Thomson; Murali Janakiram; Udupi A Ramagopal; Yael M Abadi; Jun Sik Lee; Lisa Scandiuzzi; Kim C Ohaegbulam; Jordan M Chinai; Ruihua Zhao; Yu Yao; Ying Mao; Joseph A Sparano; Steven C Almo; Xingxing Zang
Journal:  Cell Rep       Date:  2014-10-30       Impact factor: 9.423

7.  Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells.

Authors:  Hongwei Du; Koichi Hirabayashi; Sarah Ahn; Nancy Porterfield Kren; Stephanie Ann Montgomery; Xinhui Wang; Karthik Tiruthani; Bhalchandra Mirlekar; Daniel Michaud; Kevin Greene; Silvia Gabriela Herrera; Yang Xu; Chuang Sun; Yuhui Chen; Xingcong Ma; Cristina Rosa Ferrone; Yuliya Pylayeva-Gupta; Jen Jen Yeh; Rihe Liu; Barbara Savoldo; Soldano Ferrone; Gianpietro Dotti
Journal:  Cancer Cell       Date:  2019-02-11       Impact factor: 31.743

8.  Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.

Authors:  Sangbin Lim; Hao Liu; Luciana Madeira da Silva; Ritu Arora; Zixing Liu; Joshua B Phillips; David C Schmitt; Tung Vu; Steven McClellan; Yifeng Lin; Wensheng Lin; Gary A Piazza; Oystein Fodstad; Ming Tan
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

9.  Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.

Authors:  Elodie Picarda; Kim C Ohaegbulam; Xingxing Zang
Journal:  Clin Cancer Res       Date:  2016-05-20       Impact factor: 12.531

10.  Structure and Dynamics of PD-L1 and an Ultra-High-Affinity PD-1 Receptor Mutant.

Authors:  Roberta Pascolutti; Xianqiang Sun; Joseph Kao; Roy L Maute; Aaron M Ring; Gregory R Bowman; Andrew C Kruse
Journal:  Structure       Date:  2016-09-08       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.